Global Amifostine Market Analysis 2011-2017 and Forecast 2018-2023

ReportPage
Report ID
7962
Published Date
30-Oct
No of Report Page
89
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $5,960.00
US $5,960.00
US $2,980.00

  • Report Details

    Snapshot
    Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
    The global Amifostine market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, t

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Amifostine Industry
    1.1.1 Overview
    1.1.2 Development of Amifostine
    1.2 Market Segment
    1.2.1 Upstream
    1.2.2 Downstream
    1.3 Cost Analysis
    2 Industry Environment
    2.1 Policy
    2.2 Economics
    2.3 Sociology
    2.4 Technology
    3 Amifostine Market by Type
    3.1 Segment Overview
    3.1.1 400mg/Dose
    3.

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample